02.11.2022 • News

Curia Begins Work on New Mexico Expansion

US CDMO Curia has begun construction on an expansion of its campus in Albuquerque, New Mexico. The facility designed by Burns & McDonnell will be built by BE&K Building Group.

Improvements will include a new advanced isolated high-speed fill-finish vial line, which includes biosafety level 2 (BSL-2) containment as well as two lyophilizers for the high-speed fill-finish and an isolated flexible filling line for vials, syringes and cartridges to support smaller-batch advanced therapies.

The flexible filling line and high-speed fill-finish vial lines are planned to be operational in 2025.

Backing the expansion project designed to support the domestic production of injectable medicines are US preparedness authorities such as Biomedical Advanced Research and Development Authority (BARDA) and the Administration for Strategic Preparedness and Response (ASPR), both part of the Department of Health and Human Services (HHS), as well as the Department of Defense and the US Army Contracting Command’s Joint Covid Response Division.

The US state of New Mexico is also supporting the expansion through assistance from the Local Economic Development Act (LEDA) job creation fund, and Curia can expect state assistance for employee job training. The CDMO said the expansion will allow it to make a greater contribution to the production of vaccines and treatments.

Author: Dede Williams, Freelance Journalist
 

Event included Gov. Michelle Lujan Grisham, Economic Development Cabinet...
Event included Gov. Michelle Lujan Grisham, Economic Development Cabinet Secretary, Alicia J. Keyes and Albuquerque Mayor Tim Keller. © Curia

Company

Logo:

Curia


Albany, NY
US

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.